![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy |
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang |
Radiation Oncology Journal. 2022;40(2):111-119. Published online 2022 May 20 DOI: https://doi.org/10.3857/roj.2021.01060 |
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy Elevated Absolute Monocyte Count, Absolute Neutrophil Count, and Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy Pre-treatment Neutrophil to Lymphocyte ratio (NLR) is a Prognostic Biomarker for Overall Survival in Localized Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy Prognostic Factors for Elderly Patients Treated With Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma Post-Stereotactic Body Radiation Therapy (SBRT) Neutrophil-to-Lymphocyte Ratio (NLR) in Patients With Borderline Resectable Pancreatic Cancer (BRPC) May Be a Prognostic Biomarker Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal clinical cutoff point Post-treatment neutrophil-to-lymphocyte ratio (NLR) is an independent prognostic marker in patients with localized pancreatic cancer treated with neoadjuvant therapy Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy: An Analysis Focusing on Metastases What is the Prognostic Significance of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Patients Treated With Selective Internal Radiation Therapy? Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy |
This metadata service is kindly provided by CrossRef from May 29, 2014. Radiat Oncol J has participated in CrossRef Text and Data Mining service since October 29, 2014. |